Download PDF
Nervenheilkunde 2006; 25(11): 941-950
DOI: 10.1055/s-0038-1626803
Originaler Artikel
Schattauer GmbH

Demenz bei Parkinson-Syndromen

Lewy-Körper-Demenz, idiopathisches und andere Parkinson Syndrome, Normaldruckhydrozephalus 1. Teil – KlinikClinical picture of dementia in ParkinsonismDementia with Lewy bodies (DLB), Parkinson’s disease, vascular parkinsonism and normal pressure hydrocephalus
A. O. Ceballos-Baumann
1   Neurologisches Krankenhaus München
› Author Affiliations
Further Information

Publication History

Publication Date:
18 January 2018 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Eine Demenz betrifft mehr als 10% der über 75-Jährigen. Kombinationen verschiedener Parkinson-Symptome wie Gangstörung, Bradykinese, Tremor und Rigor weisen mehr als 20% aller über 75-Jährigen auf. 75% der Patienten mit einem idiopathischem Parkinson-Syndrom (IPS) entwickeln 8 Jahre nach Diagnosestellung eine Demenz. Zu einer Demenz bei Parkinson-Syndromen kommt es früh im Verlauf bei der Lewy-Körper-Demenz (LKD) und spät beim IPS, bei der progressiven supranuklären Blickparese (PSP), bei der kortikobasalen Degeneration (CBD), seltener bei den frontotemporalen Demenzen. Bei der PSP, dem vaskulären Parkinson Syndrom/der vaskulären Demenz im Rahmen einer subkortikalen vaskulären Enzephalopathie (SVE) und dem Normaldruckhydrozephalus (NPH) dominiert als Parkinson-Symptom eine Gangund Standunsicherheit (Parkinson-Syndrom der unteren Körperhälfte). Das Erkennen einer Demenz bei einem Parkinson-Syndrom sollte es erlauben, das Auftreten von Verwirrtheit und Psychosen durch Antiparkinsonika zu reduzieren (Patienten mit Demenz reagieren besonders schnell mit Verwirrtheit und Halluzinose auf bestimmte Parkinson-Medikamente). Das Erkennen von Parkinson-Symptomen bei einer dementiellen Entwicklung sollte wiederum helfen, die Inzidenz von motorischer und kognitiver Verschlechterung durch Neuroleptika zu reduzieren (Patienten mit Parkinson-Syndromen reagieren besonders empfindlich nicht nur auf typische, sondern auch auf atypische Neuroleptika). Die vorliegende Übersicht erläutert im ersten Teil die Klinik dieser überlappenden Syndrome und diskutiert in einem zweiten Teil die Therapie.

Summary

Dementia can be diagnosed in at least 10% and parkinsonian signs in more than 20% of the general population over 75 years of age. The association of dementia and parkinsonism occurs in 75% of patients with classical Parkinson´s disease after an eight year course. Parkinsonism occurs in dementia with Lewy bodies (DLB), in progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) less so in other diseases associated with the Pick-complex (frontotemporal dementias). Gait and postural parkinsonian signs predominate in PSP, vascular parkinsonism/dementia and normal pressure hydrocephalus (NPH) (lower body parkinsonism). This review discusses in the first part the different disorders associated with parkinsonism and dementia and in a second part its management. Diagnostic differentiation of the dementia-parkinsonism disorders may help to avoid two common problems: 1. delirium and psychosis are often induced by antiparkinsonian drugs and 2. neuroleptics exacerbate parkinsonian signs and cognitve deficits.

Schlüsselwörter

Parkinson-Syndrom - Demenz - Cholinesterasehemmer - Dopaminergika

Keywords

Parkinson’s disease - dementia with Lewy bodies (DLB) - cholinesterase inhibitors - dopaminergics
 

  • Literatur

  • 1 Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sorensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8– year prospective study. Arch Neurol 2003; 60: 387-92.
    CrossrefPubMedGoogle Scholar
  • 2 Aarsland D, Larsen JP, Tandberg E, Laake K. Predictors of nursing home placement in Parkinson’s disease: a population-based, prospective study. J Am Geriatr Soc 2000; 48: 938-42.
    CrossrefPubMedGoogle Scholar
  • 3 Atchison PR. et al. The syndrome of gait ignition failure:a report of six cases. Mov Disord 1993; 08: 285-92.
    CrossrefPubMedGoogle Scholar
  • 4 Baezner H. et al. Subkortikale vaskuläre Enzephalopathie. Akt Neurol 2003; 30: 266-80.
    Article in Thieme ConnectGoogle Scholar
  • 5 Bak TH. et al. Cognitive bedside assessment in atypical parkinsonian syndromes. J Neurol Neurosurg Psychiatry 2005; 76: 420-2.
    CrossrefPubMedGoogle Scholar
  • 6 Ballard C. et al. One year follow-up of parkinsonism in dementia with Lewy bodies. Dement Geriatr Cogn Disord 2000; 11: 219-22.
    CrossrefPubMedGoogle Scholar
  • 7 Bennett DA. et al. Prevalence of parkinsonian signs and associated mortality ina community population of older people. N Engl J Med 1996; 334: 71-6.
    CrossrefPubMedGoogle Scholar
  • 8 Ceballos-Baumann AO, Kurz A. Parkinson-Syndrome mit Demenz. In: Ceballos-Baumann AO, Conrad B. editors. Bewegungsstörungen in der Neurologie. Stuttgart, New York: Thieme; 2005: 106-27.
    Google Scholar
  • 9 Ceballos-Baumann AO, Lemke MR. ParkinsonSyndrom und Depression. Nervenheilkunde 2004; 23: 143-50.
    Article in Thieme ConnectGoogle Scholar
  • 10 Critchley M. Arteriosclerotic parkinsonism. Brain 1929; 52: 23-83.
    CrossrefGoogle Scholar
  • 11 de Lau LM, Schipper CM, Hofman A, Koudstaal PJ, Breteler MM. Prognosis of Parkinson disease: risk of dementia and mortality: the Rotterdam Study. Arch Neurol 2005; 62: 1265-9.
    CrossrefPubMedGoogle Scholar
  • 12 Fitzgerald PM, Jankovic J. Lower body parkinsonism. Evidence for vascular etiology. Mov Disord 1989; 04: 249-60.
    CrossrefPubMedGoogle Scholar
  • 13 Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999; 56: 33-9.
    CrossrefPubMedGoogle Scholar
  • 14 Gilman S, Low PA, Quinn N, Albanese A, BenShlomo Y, Fowler CJ. et al. Consensus statement on the diagnosis of multiple system atrophy [see comments]. J Neurol Sci 1999; 163: 94-8.
    CrossrefPubMedGoogle Scholar
  • 15 Goetz CG, Stebbins GT. Mortality and hallucinations in nursing home patients with advanced Parkinson’s disease. Neurology 1995; 45: 669-71.
    CrossrefPubMedGoogle Scholar
  • 16 Grimes DA. et al. Dementia as the most common presentation of cortical-basal ganglionic degeneration. Neurology 1999; 53: 1969-74.
    CrossrefPubMedGoogle Scholar
  • 17 Hansen LA, Samuel W. Criteria for Alzheimer’s disease and the nosology of dementia with Lewy bodies. Neurology 1997; 48: 126-32.
    CrossrefPubMedGoogle Scholar
  • 18 Hayflick SJ, Westaway SK, Levinson B, Zhou B, Johnson MA, Ching KH. et al. Genetic, clinical, and radiographic delineation of HallervordenSpatz syndrome. N Engl J Med 2003; 348: 33-40.
    CrossrefPubMedGoogle Scholar
  • 19 Hely MA, Morris JG, Reid WG, Trafficante R. Sydney Multicenter Study of Parkinson’s disease: non-L-dopa-responsive problems dominate at 15 years. Mov Disord 2005; 20: 190-9.
    CrossrefPubMedGoogle Scholar
  • 20 Hodges JR, Davies RR, Xuereb JH, Casey B, Broe M, Bak TH. et al. Clinicopathological correlates in frontotemporal dementia. Ann Neurol 2004; 56: 399-406.
    CrossrefPubMedGoogle Scholar
  • 21 Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson’s disease: a clinicopathologic study [published erratum appears in Neurology 1992; 42: 1436] [see comments]. Neurology 1992; 42: 1142-6.
    CrossrefPubMedGoogle Scholar
  • 22 Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002; 125 (Pt 4): 861-70.
    CrossrefPubMedGoogle Scholar
  • 23 Hughes TA, Ross HF, Musa S, Bhattacherjee S, Nathan RN, Mindham RH. et al. A 10-year study of the incidence of and factors predicting dementia in Parkinson’s disease. Neurology 2000; 54: 1596-602.
    CrossrefPubMedGoogle Scholar
  • 24 Kertesz A. Pick’s complex and FTDP-17. Mov Disord 2003; 18 (Suppl. 06) S57-62.
    CrossrefPubMedGoogle Scholar
  • 25 Kosaka K, Mehraein P. Dementia-Parkinsonism syndrome with numerous Lewy bodies and senile plaques in cerebral cortex. Arch Psychiatr Nervenkr 1979; 226: 241-50.
    CrossrefPubMedGoogle Scholar
  • 26 Kosaka K, Oyanagi S, Matsushita M, Hori A. Presenile dementia with Alzheimer-, Pickand Lewybody changes. Acta Neuropathol (Berl) 1976; 36: 221-33.
    CrossrefPubMedGoogle Scholar
  • 27 Krauss JK. et al. Vascular risk factors and arteriosclerotic disease in idiopathic normal-pressure hydrocephalus of the elderly. Stroke 1996; 27: 24-9.
    CrossrefPubMedGoogle Scholar
  • 28 Litvan I, Agid Y, Goetz C, Jankovic J, Wenning GK, Brandel JP. et al. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology 1997; 48: 119-25.
    CrossrefPubMedGoogle Scholar
  • 29 Lopez OL, Wisnieski SR, Becker JT, Boller F, DeKosky ST. Extrapyramidal signs in patients with probable Alzheimer disease. Arch Neurol 1997; 54: 969-75.
    CrossrefPubMedGoogle Scholar
  • 30 Louis ED, Luchsinger JA. History of vascular disease and mild parkinsonian signs in community-dwelling elderly individuals. Arch Neurol 2006; 63: 717-22.
    CrossrefPubMedGoogle Scholar
  • 31 Maltete D, Guyant-Marechal L, Mihout B, Hannequin D. Movement disorders and Creutzfeldt-Jakob disease: A review. Parkinsonism Relat Disord 2006; 12: 65-71.
    CrossrefPubMedGoogle Scholar
  • 32 Mark MH, Sage JI, Walters AS, Duvoisin RC, Miller DC. Binswanger’s disease presenting as levodopa-responsive parkinsonism: clinicopathologic study of three cases [see comments]. Mov Disord 1995; 10 (04) 450-4.
    CrossrefPubMedGoogle Scholar
  • 33 Matthews BR, Jones LK, Saad DA, Aksamit AJ, Josephs KA. Cerebellar ataxia and central nervous system whipple disease. Arch Neurol 2005; 62: 618-20.
    CrossrefPubMedGoogle Scholar
  • 34 McKeith IG, Ballard CG, Perry RH, Ince PG, O’Brien JT, Neill D. et al. Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology 2000; 54: 1050-8.
    CrossrefPubMedGoogle Scholar
  • 35 McKeith IG, Dickson DW, Lowe J, Emre M, O’Brien JT, Feldman H. et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005; 65: 1863-72.
    CrossrefPubMedGoogle Scholar
  • 36 Merello M, Sabe L, Teson A, Migliorelli R, Petracchi M, Leiguarda R. et al. Extrapyramidalism in Alzheimer’s disease: prevalence, psychiatric, and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1994; 57: 1503-9.
    CrossrefPubMedGoogle Scholar
  • 37 Muslimovic D, Post B, Speelman JD, Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 2005; 65: 1239-45.
    CrossrefPubMedGoogle Scholar
  • 38 Ondo WG, Chan LL, Levy JK. Vascular parkinsonism: clinical correlates predicting motor improvement after lumbar puncture. Mov Disord 2002; 17: 91-7.
    CrossrefPubMedGoogle Scholar
  • 39 Rebeiz J, Kolodny EH, Richardson EP. Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 1968; 18: 20-33.
    CrossrefPubMedGoogle Scholar
  • 40 Riedel-Heller SG, Busse A, Aurich C, Matschinger H, Angermeyer MC. Prevalence of dementia according to DSM-III-R and ICD-10: results of the Leipzig Longitudinal Study of the Aged (LEILA75+) Part 1. Br J Psychiatry 2001; 179: 250-4.
    CrossrefPubMedGoogle Scholar
  • 41 Scarmeas N, Hadjigeorgiou GM, Papadimitriou A, Dubois B, Sarazin M, Brandt J. et al. Motor signs during the course of Alzheimer disease. Neurology 2004; 63: 975-82.
    CrossrefPubMedGoogle Scholar
  • 42 Sibon I, Fenelon G, Quinn NP, Tison F. Vascular parkinsonism. J Neurol 2004; 251: 513-24.
    CrossrefPubMedGoogle Scholar
  • 43 Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy.A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964; 10: 333-58.
    CrossrefPubMedGoogle Scholar
  • 44 Stevens T, Livingston G, Kitchen G, Manela M, Walker Z, Katona C. Islington study of dementia subtypes in the community. BrJ Psychiatry 2002; 180: 270-6.
    CrossrefPubMedGoogle Scholar
  • 45 Van Gerpen JA, Kumar N, Bower JH, Weigand S, Ahlskog JE. Levodopa-associated dyskinesia risk among Parkinson disease patients in Olmsted County, Minnesota, 1976–1990. Arch Neurol 2006; 63: 205-9.
    CrossrefPubMedGoogle Scholar
  • 46 Walshe JM, Yealland M. Wilson’s disease: the problem of delayed diagnosis. J Neurol Neurosurg Psychiatry 1992; 55: 692-6.
    CrossrefPubMedGoogle Scholar
  • 47 Wielinski CL, Erickson-Davis C, Wichmann R, Walde-Douglas M, Parashos SA. Falls and injuries resulting from falls among patients with Parkinson’s disease and other parkinsonian syndromes. Mov Disord 2005; 20: 410-5.
    CrossrefPubMedGoogle Scholar
  • 48 Williams DR, Lees AJ. Visual hallucinations in the diagnosis of idiopathic Parkinson’s disease: a retrospective autopsy study. Lancet Neurol 2005; 04: 605-10.
    CrossrefPubMedGoogle Scholar
  • 49 Winikates J, Jankovic J. Clinical correlates of vascular parkinsonism. Arch Neurol 1999; 56: 98-102.
    CrossrefPubMedGoogle Scholar
  • 50 Zijlmans JC, Katzenschlager R, Daniel SE, Lees AJ. The L-dopa response in vascular parkinsonism. J Neurol Neurosurg Psychiatry 2004; 75: 545-7.
    CrossrefPubMedGoogle Scholar